Delivery Order SPE2DR25D2206-SPE2DR26F9FL8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count packaging) with a ceiling value of $1,733.90. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by December 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a typical transaction under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count) with a ceiling value of $2,614.99. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a contract ceiling value of $9,131.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. The contract, valued at $10,987.57, is scheduled for completion by December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under a larger Indefinite Delivery Contract vehicle and was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count units) with a ceiling value of $26,647.13. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is set for ultimate completion by December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single task under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units, with a ceiling value of $7,625.49. This competitively awarded, non-set-aside order features firm fixed pricing and is scheduled for completion by November 5, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $6,820.63. This is a firm fixed price delivery order with no set-aside designation, reflecting an open and competitive procurement. The work is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and must be completed by November 4, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Ondansetron ODT 8 mg tablets in a quantity of 30-count packages, with a ceiling value of $1,733.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the delivery is scheduled for completion by June...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $14,188.55 and an ultimate completion date of October 8, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units, with a contract ceiling value of $7,608.34 and an ultimate completion date of December 2, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania corporate office. The delivery order is issued under AmerisourceBergen Drug...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9FL8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This contract is a firm fixed price delivery order with a ceiling value of $11,416.54 and an ultimate completion date of December 12, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. This award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen provides a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The contract supports medical procurement needs across multiple therapeutic domains and enables the company to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible vehicle designed to meet diverse and evolving pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 12/10/25 |